MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$2,133K
Free Cash flow
$27,283K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Revolving facility proceeds-JPMC...
    • Net income
    • Accounts payable
    • Others
Negative Cash Flow Breakdown
    • Acquisition of treasury stock
    • Inventories
    • Accrued expenses
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
37,822
45,328
49,379
36,429
Depreciation and amortization
1,781
1,839
2,046
2,023
Gain on sale of plasma centers
0
7,980
-
-
Loss on disposal of fixed assets
0
-42
-9
0
Deferred income tax provision
-
-
-11,020
-
Interest paid in kind
-
-
0
-
Deferred income tax provision
3
-6,556
-
4,803
Stock-based compensation
6,135
6,329
5,392
5,047
Amortization of debt discount
192
191
197
170
Loss on extinguishment of debt
0
-
0
-2,177
Amortization of license revenue
-35
-36
-36
-36
Accounts receivable
2,369
-22,567
20,756
27,948
Inventories
17,215
15,633
9,798
5,203
Prepaid expenses and other current assets
-420
1,601
547
-1,117
Deposits and other assets
401
-379
-540
-45
Accounts payable
10,079
-1,233
-2,203
-4,876
Accrued expenses
-6,583
5,105
10,639
-221
Other current and non-current liabilities
-290
-340
-395
-234
Net cash provided by operating activities
29,539
58,249
35,639
13,293
Purchase of property and equipment
2,256
2,543
1,084
14,368
Acquisition of intangible assets
0
53
192
0
Deposit received on net assets held for sale
-
-
1,000
-
Proceeds on the sales of assets held for sale
0
5,000
-
-
Net cash provided by (used in) investing activities
-2,256
2,404
-276
-14,368
Term loan payments-Ares Credit Facility
-
-
0
32,500
Ares revolving facility payments-Ares Credit Facility
-
-
0
72,500
Term loan payments-Ares Revolving Facility
0
-
-
-
Ares revolving facility proceeds-Ares Credit Facility
-
-
0
30,000
Revolving facility proceeds-Ares Revolving Facility
0
-
-
-
Term loan payments-JPMCredit Facilities
469
469
469
469
Jpm revolving facility proceeds
-
125,000
0
75,000
Revolving facility proceeds-JPMCredit Facilities
125,000
-
-
-
Prepayment penalties on repayment of debt
0
-
0
581
Proceeds from issuance of note payable
-
-
0
-
Taxes paid on vested restricted stock units
3,928
5,058
164
964
Payments on finance lease obligations
-
-
0
-
Debt issuance costs
-
-
13
2,224
Net proceeds from the exercise of stock options
35
588
430
389
Payment of end of term fee
0
-
0
938
Payment of deferred financing fees
-
-
0
-
Acquisition of treasury stock
25,054
130,191
8,902
23,038
Net cash used in financing activities
-29,416
-10,130
-9,118
-27,825
Net increase (decrease) in cash and cash equivalents
-2,133
50,523
26,245
-28,900
Cash and cash equivalents - beginning of period
138,153
87,630
61,385
103,147
Cash and cash equivalents - end of period
136,020
138,153
87,630
61,385
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net income$37,822K (-38.12%↓ Y/Y)Accounts payable$10,079K (7.12%↑ Y/Y)Stock-based compensation$6,135K (-36.01%↓ Y/Y)Depreciation andamortization$1,781K (-55.77%↓ Y/Y)Prepaid expenses andother current assets-$420K (-120.05%↓ Y/Y)Amortization of debt discount$192K (-45.14%↓ Y/Y)Deferred income taxprovision$3K (-99.94%↓ Y/Y)Net cash provided byoperating activities$29,539K (1917.69%↑ Y/Y)Canceled cashflow$26,893K Net increase(decrease) in cash and cash...-$2,133K (83.42%↑ Y/Y)Canceled cashflow$29,539K Revolving facilityproceeds-JPMCredit Facilities$125,000K Net proceeds fromthe exercise of...$35K (-98.38%↓ Y/Y)Inventories$17,215K (-18.91%↓ Y/Y)Accrued expenses-$6,583K (-26.45%↓ Y/Y)Accounts receivable$2,369K (-96.03%↓ Y/Y)Deposits and other assets$401K (31.05%↑ Y/Y)Other current andnon-current liabilities-$290K (51.83%↑ Y/Y)Amortization of licenserevenue-$35K (50.70%↑ Y/Y)Net cash used infinancing activities-$29,416K (-315.54%↓ Y/Y)Canceled cashflow$125,035K Net cash provided by(used in) investing...-$2,256K (68.87%↑ Y/Y)something is missing-$125,000K Acquisition of treasurystock$25,054K Taxes paid on vestedrestricted stock units$3,928K (-53.34%↓ Y/Y)Term loanpayments-JPMCredit Facilities$469K Purchase of property andequipment$2,256K (-68.33%↓ Y/Y)
ADMA logo-svg

ADMA BIOLOGICS, INC. (ADMA)

ADMA logo-svg

ADMA BIOLOGICS, INC. (ADMA)